125 related articles for article (PubMed ID: 37165519)
21. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
Lo Giudice G; Avarello A; Campana G; Galan A
Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
[TBL] [Abstract][Full Text] [Related]
22. Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.
Yuksel B; Karti O; Celik O; Kerci SG; Kusbeci T
Clin Exp Optom; 2018 Jan; 101(1):116-122. PubMed ID: 28922697
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.
Gumus G; Erdogan G; Gunay BO; Karatas Durusoy G
Ophthalmologica; 2022; 245(5):439-445. PubMed ID: 35921811
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
[TBL] [Abstract][Full Text] [Related]
26. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
[TBL] [Abstract][Full Text] [Related]
27. Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting.
Corbelli E; Fasce F; Iuliano L; Sacconi R; Lattanzio R; Bandello F; Querques G
Acta Diabetol; 2020 Oct; 57(10):1193-1201. PubMed ID: 32367246
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema.
Koc H; Alpay A; Ugurbas SH
BMC Ophthalmol; 2023 Mar; 23(1):97. PubMed ID: 36915060
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study.
Fraser-Bell S; Kang HK; Mitchell P; Arnold JJ; Tainton J; Simonyi S
Br J Ophthalmol; 2023 Jan; 107(1):72-78. PubMed ID: 34433549
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.
Li X; Wang N; Liang X; Xu G; Li XY; Jiao J; Lou J; Hashad Y;
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):59-69. PubMed ID: 29119239
[TBL] [Abstract][Full Text] [Related]
31. INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY.
Maturi RK; Pollack A; Uy HS; Varano M; Gomes AM; Li XY; Cui H; Lou J; Hashad Y; Whitcup SM;
Retina; 2016 Jun; 36(6):1143-52. PubMed ID: 26871523
[TBL] [Abstract][Full Text] [Related]
32. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
33. Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.
Cho H; Choi KS; Lee JY; Lee D; Choi NK; Lee Y; Bae S
BMJ Open; 2019 Sep; 9(9):e030930. PubMed ID: 31542758
[TBL] [Abstract][Full Text] [Related]
34. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y
Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512
[TBL] [Abstract][Full Text] [Related]
35. Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.
Cornish EE; Teo KY; Gillies MC; Lim LL; Nguyen V; Wickremasinghe S; Mehta H; McAllister IL; Fraser-Bell S
Br J Ophthalmol; 2023 Jan; 107(1):79-83. PubMed ID: 34340975
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
Kong X; Psaras C; Stewart JM
Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
[TBL] [Abstract][Full Text] [Related]
37. Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study.
Sweta VD; Shibi Dev BN; Sandhya R
Indian J Ophthalmol; 2022 Feb; 70(2):585-589. PubMed ID: 35086242
[TBL] [Abstract][Full Text] [Related]
38. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
[TBL] [Abstract][Full Text] [Related]
40. Immortal Ozurdex: A 10-month follow-up of an intralenticular implant.
Poornachandra B; Kumar VBM; Jayadev C; Dorelli SH; Yadav NK; Shetty R
Indian J Ophthalmol; 2017 Mar; 65(3):255-257. PubMed ID: 28440260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]